To validate these results in two independent datasets based on RNA expression,30 we used the KMT2A fusion partner to group KMT2Ar-AML cases into MLLGA, MLLGB and the intermediate MLLT3/MLLT11 group. Here, MLLT11 is linked to acute myeloid leukemia.